Jagsonpal Pharmaceuticals share price
You have to be logged in to add this to Watchlist.- ₹176.30(-1.59%)January 16, 2026 15:15:48 PM IST
- NSE
- BSE
- Vol : 33.83 K (NSE + BSE)Last 20 day avg : 45.57 K
Jagsonpal Pharmaceuticals is trading -1.59% lower at Rs 176.30 as compared to its last closing price. Jagsonpal Pharmaceuticals has been trading in the price range of 178.90 & 174.60. Jagsonpal Pharmaceuticals has given -8.45% in this year & -5.95% in the last 5 days. Jagsonpal Pharmaceuticals has TTM P/E ratio 23.84 as compared to the sector P/E of 22.30.The company posted a net profit of 12.57 Crores in its last quarter.Listed peers of Jagsonpal Pharmaceuticals include Pfizer (-1.29%), Unichem Laboratories (-2.66%), Aurobindo Pharma (-1.04%).The Mutual Fund holding in Jagsonpal Pharmaceuticals was at 0.11% in 30 Sep 2024. The MF holding has - from the last quarter. The FII holding in Jagsonpal Pharmaceuticals was at 2.12% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jan 19, 2026, 02:39 AM UTC
- BetaLow volatility0.25Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.04The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldHigher than industry1.40Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation0.46The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Pfizer | Bearish | 4,757.00 | -1.29 | 21,764.03 | 36.12 | 5.46 | 0.69 | 1.60 |
| Unichem Laboratories | Bearish | 401.25 | -2.66 | 2,835.59 | 23.18 | 1.29 | - | 3.51 |
| Aurobindo Pharma | Neutral | 1,168.00 | -1.04 | 68,087.37 | 20.15 | 2.15 | 0.33 | 5.52 |
| Themis Medicare | Bearish | 91.85 | -4.22 | 845.94 | 31.81 | 2.35 | 0.49 | 4.62 |
| Neuland Laboratories | Moderately Bearish | 14,060.00 | -1.46 | 18,051.08 | 92.96 | 12.69 | 0.08 | 7.17 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-01-21 | Quarterly Results |
| 2025-11-03 | Quarterly Results |
| 2025-07-26 | Quarterly Results |
| 2025-05-06 | Audited Results & Final Dividend |
| 2025-01-22 | Quarterly Results |
- IndustryMajor Drugs
- ISININE048B01035
- BSE Code507789
- NSE CodeJAGSNPHARM
Jagsonpal Pharmaceuticals is trading at 176.30 as on Fri Jan 16 2026 09:45:48. This is -1.59% lower as compared to its previous closing price of 179.15.
The market capitalization of Jagsonpal Pharmaceuticals is 1176.69 Cr as on Fri Jan 16 2026 09:45:48.
The 52 wk high for Jagsonpal Pharmaceuticals is 301.80 whereas the 52 wk low is 176.05
Jagsonpal Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 23.84
- Sector P/E: 22.30
- Dividend Yield: 1.42%
- D/E ratio: 0.03
Jagsonpal Pharmaceuticals reported a net profit of 55.36 Cr in 2025.
The Mutual Fund Shareholding was 0.11% at the end of 30 Sep 2024.
EQUITY QUICK LINKS
Jagsonpal Pharmaceuticals QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.